Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double Blind (DB), up to Week 48	STARTED	Placebo	12
Double Blind (DB), up to Week 48	STARTED	Obeticholic Acid (OCA)	10
Double Blind (DB), up to Week 48	COMPLETED	Placebo	4
Double Blind (DB), up to Week 48	COMPLETED	Obeticholic Acid (OCA)	6
Double Blind (DB), up to Week 48	NOT COMPLETED	Placebo	8
Double Blind (DB), up to Week 48	NOT COMPLETED	Obeticholic Acid (OCA)	4
DB Extension, Week 48 up to 3 Years	STARTED	Placebo	4
DB Extension, Week 48 up to 3 Years	STARTED	Obeticholic Acid (OCA)	6
DB Extension, Week 48 up to 3 Years	COMPLETED	Placebo	0
DB Extension, Week 48 up to 3 Years	COMPLETED	Obeticholic Acid (OCA)	0
DB Extension, Week 48 up to 3 Years	NOT COMPLETED	Placebo	4
DB Extension, Week 48 up to 3 Years	NOT COMPLETED	Obeticholic Acid (OCA)	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03633227/flow